Search Header Logo
Canadian Ebola Vaccine to Start Clinical Trials Today

Canadian Ebola Vaccine to Start Clinical Trials Today

Assessment

Interactive Video

Business, Health Sciences, Biology

University

Hard

Created by

Wayground Content

FREE Resource

The video discusses the development of vaccines by various companies, focusing on a Canadian company and GlaxoSmithKline. GlaxoSmithKline's vaccine is in advanced testing, aiming to provide doses by January for healthcare workers in Africa. The Canadian vaccine is in early testing, with hopes to scale production. Challenges include producing enough doses quickly, especially for smaller companies like Profectus, and ensuring global distribution if the vaccine proves effective.

Read more

5 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

How many vaccines are mentioned to be in human testing or close to it?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

What is the status of the GlaxoSmithKline vaccine mentioned in the text?

Evaluate responses using AI:

OFF

3.

OPEN ENDED QUESTION

3 mins • 1 pt

What is the hope for the timeline of the Canadian vaccine's availability?

Evaluate responses using AI:

OFF

4.

OPEN ENDED QUESTION

3 mins • 1 pt

What is the main concern regarding the production of the Canadian vaccine?

Evaluate responses using AI:

OFF

5.

OPEN ENDED QUESTION

3 mins • 1 pt

What are the challenges mentioned in scaling up the production of the Canadian vaccine?

Evaluate responses using AI:

OFF

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?